- Stay Connected
Socialize
WMIS expands footprint, Becomes a key sponsor of Imaging in 2020 Meeting
World Molecular Imaging Society (WMIS) is announcing that it will sponsor and support the Imaging in 2020 conference (i2020). i2020 is a world-class meeting of imaging professionals and researchers.…
WMIS Announces Virtual Portal
World Molecular Imaging Society (WMIS) is announcing its first online portal which features the entire conference presentation videos, abstracts, workshops, and plenary sessions. Now, at the click of a button…
WMIS Conference Wins Prestigious Award
WMIS’s World Molecular Imaging Congress 2010 has won the Japan’s National Tourism Organization’s (JNTO) award. The event was recognized as one of the country’s most successful events. WMIC 2010 was…
Kerbel Gives Keynote Speech
Robert S. Kerbel, PhD, a world renowned tumor biologist and Canada Research Chair in Tumor Biology, Angiogenesis & Antiangiogenic Therapy at Sunnybrook Research Institute University of Toronto gave the keynote…
Gelovani Takes Presidency of WMIS
Dr. Juri Gelovani assumed the role of President of WMIS as Dr. Robert Gillies transitioned out of that role after merger of two prestigious organizations – Academy of Molecular Imaging…
WMIS Renews its Commitment
Not just preclinical and basic sciences, WMIS is developing sophisticated capabilities to provide better support for translational and clinical needs. With a powerful footprint in preclinical and basic sciences, WMIS…
Surgeon captivates audience
Surgeon Gooitzen M. van Dam of University Medical Center Groningen, Groningen, Netherlands captivated the audience at WMIC 2011 by demonstrating the novel solution developed with collaboration between him and Vasillis…
WMIC Convention Powers The Molecular Imaging Industry
The Annual World Molecular Imaging Conference (WMIC), held in San Diego CA on Sep 7-10, 2011, has once again attracted a growing number of exhibitors and visitors. The 2011 WMIC…
Successful Industry Collaboration Leads to Another Collective Victory: WMIS Launches Clinical Trials for Sodium Fluoride (F-18) for CMS
Successful Industry Collaboration Leads to Another Collective Victory: WMIS Launches Clinical Trials for Sodium Fluoride (F-18) for CMS — Trial is Critical for PET Reimbursement — With the success of…
AMI and SMI Merge to form WMIS
Bob Gillies, former president of WMIS and Juri Gelovani, the new president of WMIS announced the merger of SMI and AMI to form the world’s most prestigious and advanced molecular…
